A Historic Moment for Proton Therapy: Lancet Study Confirms Survival Benefit for Head and Neck Cancer Patients
Proton therapy made history this week with groundbreaking results published in The Lancet. A new Phase III randomized clinical trial has provided the strongest evidence to date — Level 1 evidence — showing that proton therapy significantly improves survival for patients with oropharyngeal cancer compared to traditional photon-based radiation therapy.
Landmark Findings in Cancer Survival and Quality of Life
This multi-institutional study, led by researchers at The University of Texas MD Anderson Cancer Center, is the largest of its kind and the first to demonstrate a clear survival advantage for proton therapy. Compared to standard radiation, patients treated with proton therapy experienced:
- 10% higher five-year overall survival rate
- 42% reduction in the hazard of death
- Significantly fewer severe side effects, including less feeding tube dependence, dry mouth, swallowing difficulty, and immune suppression
These outcomes highlight not only improved survival, but also a meaningful boost in patient quality of life — an essential goal in modern cancer care.
What This Means for Cancer Patients
With this important advancement, the National Association for Proton Therapy (NAPT) has called for immediate access to proton therapy for all eligible patients with head and neck cancers. This moment marks a turning point in oncology, reinforcing the clinical and ethical importance of making cutting-edge proton therapy widely available.
At Ackerman Cancer Center, we are proud to be one of the few centers in the region offering proton therapy for cancer treatment. Our team is committed to providing patients with access to the most advanced, evidence-based therapies that enhance both longevity and day-to-day well-being.
Why Proton Therapy Matters
Proton therapy delivers precise, targeted radiation that minimizes damage to surrounding healthy tissue. For cancers located near vital structures — such as in the head and neck — this precision is especially critical. By reducing unnecessary exposure, proton therapy not only controls cancer effectively but also helps patients maintain their quality of life during and after treatment.
Learn More
For patients and families exploring treatment options, proton therapy represents hope, innovation, and proven effectiveness. To read the abstract, visit https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01962-2/abstract. To learn more about Ackerman Cancer Center’s proton therapy program and patient success stories, visit https://ackermancancercenter.com/what-is-proton-therapy/ or contact our team to schedule a consultation.



